Cayman Chemical Immuno-Oncology Screening Library

Tuesday, 05 March, 2024 | Supplied by: Sapphire Bioscience


Cayman Chemical’s Immuno-Oncology Screening Library consists of two plates and contains more than 90 cancer and immunology-associated compounds in a 96-well Matrix tube rack format as 10 mM stock solutions in DMSO.

The library includes a variety of immuno-oncology target modulators, including but not limited to: adenosine, CCR, CXCR and TLR agonists and antagonists; BTK, PI3K, VEGFR and BRAF inhibitors; PD-1/PD-L1 interaction inhibitors; and HDAC inhibitors. Panels are routinely re-evaluated to include new catalogue introductions as the research evolves.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

ProSci Incorporated apoptosis antibodies

ProSci Incorporated provides an extensive catalogue of apoptotic antibodies including death...

TdB Labs polysaccharides

TdB Labs' polysaccharide portfolio consists of both fluorescent and non-fluorescent...

Cayman Chemical Epigenetics Screening Library (96-Well)

The Cayman Chemical Epigenetics Screening Library (96-Well) is a compound library that is...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd